Anaphylactic shock caused by iodixanol: a case report

doi:10.3760/cma.j.issn.1007-1245.2023.05.022

International Medicine and Health Guidance News ›› 2023, Vol. 29 ›› Issue (5): 692-694.DOI: 10.3760/cma.j.issn.1007-1245.2023.05.022

• Case Report • Previous Articles Next Articles

Anaphylactic shock caused by iodixanol: a case report

Wu Yanping, Qi Liuying

Department of Pharmacy, Songjiang District Central Hospital, Shanghai 201600, China

Received:2022-10-07 Online:2023-03-01 Published:2023-03-31
Contact: Qi Liuying, Email: 18918289049@163.com
Supported by:
Project for Construction of Key Special Subjects of Clinical Pharmacy in Shanghai (Belonging to the District) (No.20189)

碘克沙醇致过敏性休克1例

吴艳萍戚留英

上海市松江区中心医院药剂科，上海　201600

通讯作者: 戚留英，Email：18918289049@163.com
基金资助:
上海市临床药学重点专科建设项目（区属）（沪卫计药政〔2018〕9号）

Abstract

Abstract:

The clinical data of one case of anaphylactic shock caused by iodixanol in Songjiang District Central Hospital in April 2021 was analyzed, and the literatures related to the high risk factors and possible pathogenesis of anaphylactic shock caused by iodixanol were reviewed, in order to remind clinical pharmacists to pay attention to the safety of medication in the clinical use of iodixanol, and weigh the advantages and disadvantages and strengthen the medication monitoring especially for patients with specific constitution.

Key words:

Iodixanol, Anaphylactic shock, Adverse drug reactions, Iodinated contrast media

摘要：

分析2021年4月上海市松江区中心医院1例由碘克沙醇导致的过敏性休克病例并通过文献回顾碘克沙醇致过敏性休克的高危因素和可能的发病机制，旨在提醒临床上使用碘克沙醇时应注意用药安全，尤其对于特异性体质患者应该权衡利弊并加强用药监护。

关键词:

碘克沙醇, 过敏性休克, 药品不良反应, 碘对比剂

Wu Yanping, Qi Liuying.

Anaphylactic shock caused by iodixanol: a case report [J]. International Medicine and Health Guidance News, 2023, 29(5): 692-694.

吴艳萍戚留英.

碘克沙醇致过敏性休克1例 [J]. 国际医药卫生导报, 2023, 29(5): 692-694.

References

[1] 中华医学会放射学分会对比剂安全使用工作组.碘对比剂使用指南(第2版)[J].中华放射学杂志,2013,47(10):869-872. DOI:10.3760/cma.j.issn.1005-1201.2013. 10.001.
[2] 张建铭.冠心病患者PCI治疗后发生造影剂肾病的危险因素分析[J].心血管病防治知识,2019,9(30):22-24. DOI:10.3969/j.issn.1672-3015(x).2019.30.007.
[3] 国家药品不良反应监测中心.关于发布«常见严重药品不良反应技术规范及评价标准»的通知[Z].监测与评价(2010)26号.
[4] 曾亚,徐珽.碘造影剂不良反应及防治措施研究进展[J].中国药业,2022,31(3):128,后插1-后插5. DOI:10.3969/j.issn.1006-4931.2022.03.031.
[5] 赵霞,朱丛丛.冠状动脉介入碘造影剂致过敏反应的研究现状[J].中国循证心血管医学杂志,2018,10(10):1274-1275. DOI:10.3969/j.issn.1674-4055.2018.10.35.
[6] 徐志祥.碘克沙醇与碘海醇药品不良反应发生特点的对比分析[J].中国药物警戒,2018,15(2):125-128. DOI:10.3969/j.issn.1672-8629.2018.02.014.
[7] 黄俊豪.等渗造影剂碘克沙醇和低渗造影剂碘海醇对直接行PCI术老年患者的效果对比[J].中国现代药物应用,2021,15(3):33-35. DOI:10.14164/j.cnki.cn11-5581/r.2021. 03.013.
[8] 何小丽.不同类型含碘造影剂过敏反应的预防及处理原则[J].中国基层医药,2017,24(11):1685-1688. DOI:10.3760/cma.j.issn.1008-6706.2017.11.023.
[9] 徐丽婷,巩慧敏,孙爱军,等.碘克沙醇注射液引起过敏性休克致死亡1例[J].中国药物警戒,2013,10(11):701-702. DOI:10.19803/j.1672-8629.2013.11.020.
[10] 王贞,曹淑琴,庄红玲.碘克沙醇注射液致过敏性休克死亡1例[J].医药导报,2022,41(7):1056-1057. DOI:10.3870/j.issn.1004-0781.2022.07.023.
[11] 李蒙,孙昊,张劲松.药物过敏性休克的临床研究[J].实用休克杂志(中英文),2021,5(1):1-5.
[12] 海峡两岸医药卫生交流协会护理分会心血管护技专业学组.心血管介入碘对比剂使用管理护理专家共识[J].中国循环杂志,2021,36(7):625-633. DOI:10.3969/j.issn.1000- 3614.2021.07.001.
[13] Kodzwa R. Updates to the ACR manual on contrast media[J]. Radiol Technol, 2017, 89(2):186-189.
[14] 杨莲娣.利塞膦酸钠片致过敏性休克1例分析[J].中国药物警戒,2022,19(7):795-798. DOI:10.19803/j.1672-8629. 2022.07.23.
[15] 王莹,芦梦,陈星伟,等.858例对比剂致药品不良反应报告分析及探讨[J].中国医院用药评价与分析,2021,21(2):250-252,256. DOI:10.14009/j.issn.1672-2124.2021. 02.030.
[16] 李艳艳,程一帆,杨雅淋,等.碘对比剂静脉注射致皮肤不良反应的危险因素分析[J].中国药房,2020,31(18):2252-2258. DOI:10.6039/j.issn.1001-0408.2020.18.14.
[17] Kim TH, Yoon SH, Lee SY, et al. Biphasic and protracted anaphylaxis to iodinated contrast media[J]. Eur Radiol, 2018, 28(3):1242-1252. DOI: 10.1007/s00330-017- 5052-0.
[18] Kobayashi D, Takahashi O, Ueda T, et al. Risk factors for adverse reactions from contrast agents for computed tomography[J]. BMC Med Inform Decis Mak, 2013, 13:18. DOI: 10.1186/1472-6947-13-18.
[19] 赵骞,李双月,杨峰.碘造影剂过敏反应患者的危险因素分析[J].实用药物与临床,2021,24(2):164-167. DOI:10.14053/j.cnki.ppcr.202102015.
[20] 王琦,骆庆峰.过敏体质的概念、形成与调控原理[J].北京中医药大学学报,2004,27(2):6-8. DOI:10.3321/j.issn:1006-2157.2004.02.002.
[21] Rosado Ingelmo A, Doña Diaz I, Cabañas Moreno R, et al. Clinical practice guidelines for diagnosis and management of hypersensitivity reactions to contrast media[J]. J Investig Allergol Clin Immunol, 2016, 26(3):144-155; quiz 2 p following 155. DOI: 10.18176/jiaci.0058.
[22] 张步春.中国20,185例患者使用碘克沙醇的上市后监测研究[C]//中华医学会第十五次全国心血管病学大会论文集,2013:178.
[23] 胡泊,刘慧茹,曹靓,等.141例碘克沙醇不良反应报告分析[J].中国药事,2022,36(2):209-216. DOI:10.16153/j.1002-7777.2022.02.014.
[24] 中华医学会心血管病学分会介入心脏病学组,中华医学会心血管病学分会大血管病学组,中华心血管病杂志编辑委员会.经动脉心血管介入诊治中含碘对比剂相关不良反应防治的中国专家共识(2021)[J].中华心血管病杂志,2021,49(10):972-985. DOI:10.3760/cma.j.cn112148- 20210315-00224.

Anaphylactic shock caused by iodixanol: a case report

碘克沙醇致过敏性休克1例

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 3

Recommended Articles

Metrics

[1]	Wang Yanchao. Clinical effect of ilaprazole injection on peptic ulcer with hemorrhage [J]. International Medicine and Health Guidance News, 2022, 28(22): 3140-3143.
[2]	Sun Chunhua, Guo Xuedan, Xiao Xia, Wang Qi, Hua Hongxia, Zhao Fan, Huang Pei. One case of interstitial pneumonia caused by gefitinib [J]. International Medicine and Health Guidance News, 2022, 28(2): 199-201.
[3]	Li Rui, Wang Ruijie, Sun Bin, Zhang Hongguang, Yuan Ying, Qiu Jianqing. One case of multiple injuries with fever and acute liver injury caused by piperacillin sodium and tazobactam sodium [J]. International Medicine and Health Guidance News, 2022, 28(11): 1595-1597.